The results of the Swiss observational study of the new, fast-dissolving mirtazapine formulation in depressed patients

International Journal of Psychiatry in Clinical Practice

Volumn 10, Issue 2, 2006, Pages 124-130

  Delini Stula, Alexandra ^a,b   Bischof, Roland ^a  

^a ADI International Institute for Advancement of Drug Development   (Switzerland)

^b ADI International Institut   (Switzerland)

Author keywords

Antidepressants; Clinical trials; Depression; Mirtazapine; NaSSA; New formulations

Indexed keywords

MIRTAZAPINE;

ADULT; ANXIETY; ARTICLE; DEPRESSION; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG FORMULATION; EXPERIENCE; FATIGUE; FEMALE; GENDER; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL RECORD; MENTAL PATIENT; NAUSEA; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RECURRENT DISEASE; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; VERTIGO; WEIGHT GAIN; XEROSTOMIA;

EID: 33745096263     PISSN: 13651501     EISSN: 14711788     Source Type: Journal    
DOI: 10.1080/13651500600579175     Document Type: Article

References (18)

1. Kasper S. Clinical efficacy of mirtazapine:a review of meta-analysis of pooled data. Int Clin Psychopharmacol 1995;10(Suppl):25-35.
2. Mullin J, Lodge A, Bennie E, et al. A multcentre, double-blind, amitriptyline controlled study of mirtazapine in patients with major depression. J Psychopharmacol 1996;10:235-40.
3. Richou H, Ruimy P, Charbaut J, et al. A multicenter, double-blind amitriptyline controlled study of mirtazapine in patients with major depression. J Psychopharmacol 1995;10:235-40.
4. Marttila M, Jaaskelainen J, Jarvi R, et al. A double-blind study comparing the efficacy and tolerability of mirtazapine and doxepin in patients with major depression. Eur Neuropsychopharmacol 1995;5:441-6.
5. Guelfi JD, Ansseau M, Timmerman L, et al. Mirtazapine versus venlafaxine in hospitalized, severely depreed patients with melancholic features. J Clin Psychopharmacology 2001;21:425-31.
6. Szegedi A, Phillipp M, Benkert O, Kohnen R, Heinrich C, van der Vegte-Senden M, et al. More rapid onset of antidepressant efficacy with mirtazapine versus venlafaxine: A randomized, double-blind study. Int J Neuropsychopharmacol 2004;7(Suppl 1):S353.
7. Benkert O, Szegedi A, Kohnen R. Mirtazapine compared with paroxetine in major depression. J Clin Psychiatry 2000;61:656-63.
8. Leinonen E, Skarstein J, Behnke K, et al. Efficacy and tolerability of mirtazapine versus citalopram: A double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group. Int Clin Psychopharmacol 1999;14:329-37.
9. Behnke K, Sogaard J, Martin S, Bäuml J, Ravindran A, Agren H, Vester-Blokland E. Mirtazapine orally disintegrating tablet versus sertraline: A prospective onset of action study. J Clin Psychopharmacol 2003;23:358-64.
10. Lavergne F, Berlin I, Gamma A, Stassen H, Angst J. Onset of improvement and reponse to mirtazapine in depression: A milticenter naturalistic study in 4771 patients. Neuropsychiatr Dis Treat 2004;1:59-68.
11. Roose S, Nelson C, Salzman C, Hollander S, Rodrigues H. Mirtazapine Nursing Home Study Group. Curr Med Res Opin 2003;19:737-46.
12. Paykel ES, Freeling P, Hollyman JA. Are tricyclic antidepressants useful for mild depression? A placebo controlled trial. Pharmacopsychiatry 1988;21:15-8.
13. Martenyi F, Dossenbach M, Mraz K, Metcalfe S. Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients:a dopuble-blind trial of antidepressant with serotoninergic or norepinephrinergic reuptake inhibition profile. Eur Neuropsychopharmacol 2001;11:227-32.
14. Baca E, Garcia-Garcia M, Porras-Chavarino A. Gender differences in treatmenet response to sertraline versus imipramine in patients with nonmelancholic depressive disorder. Prog Neuropsychopharmacol & Biol Psychiatry 2004;28(1):57-65.
15. Bies RR, Bigos KL, Pollock BG. Gender differences in pharmacokinetics and pharmacodynamics of antidepressants. J Gend Specif Med 2003;6(3):12-20.
16. Scheibe S, Preushhof C, Cristi C, Bagby RM. Are there gender differences in major depression and its response to antidepressants? J Affect Disord 2003;75:223-35.
17. Parker G, Parker K, Austin MP, Mitchell P, Brotchie H. Gender differences in response to differing antidepressant drug classes: two negative studies. Psychol Med 2003;33:1473-5.
18. Preskorn SH. The adverse effect profiles of the selective serotonin reuptake inhibitors: relationship to in vitro pharmacology. J Psychiatr Pract 2000;6(3):153-7.